USFDA inspects Cadila Healthcare’s Pharmaceutical Technology Centre at Ahmedabad

22 Mar 2019 Evaluate

The US Food and Drug Administration (USFDA) has successfully completed an inspection at Cadila Healthcare’s Pharmaceutical Technology Centre (PTC) located at Ahmedabad, dedicated to new product development of various niche dosage forms including solid oral, parenteral, pulmonary, oncology, ointment & creams and transdermal, from March 18 to March 22, 2019. At the end of the inspection, no observations (483) have been issued.

Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.

Zydus Lifesciences Share Price

879.35 -1.75 (-0.20%)
20-Jan-2026 12:53 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1641.45
Dr. Reddys Lab 1191.65
Cipla 1381.10
Zydus Lifesciences 879.35
Lupin 2169.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×